Yahoo Web Search

  1. SNGX: Two Phase 3 Data Readouts Over the Next Two Quarters…

    Zacks Small Cap Research via Yahoo FinanceNov 14 14:40 PM

    Soligenix, Inc. (NASDAQ:SNGX) is a late-stage clinical biopharmaceutical company developing treatments in oncology, GI disorders, and biodefense. Soligenix is currently conducting the Phase ...

  1. Ads
    related to Innate Immunity LLC